Bausch + Lomb to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
03 Januar 2024 - 3:00PM
Business Wire
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye
health company dedicated to helping people see better to live
better, today announced that Chairman and CEO Brent Saunders will
participate in a fireside chat with investors at the 42nd Annual
J.P. Morgan Healthcare Conference on Jan. 8, 2024, at 11:15 a.m. PT
(2:15 p.m. ET). Other company executives, including Chief Financial
Officer Sam Eldessouky and Global Pharmaceuticals and International
Consumer President Andrew Stewart, will also participate in the
conference.
A live webcast and audio archive of the event will be available
on the Investor Relations page of the Bausch + Lomb website:
https://ir.bausch.com/investors/events-presentations.
About Bausch + Lomb
Bausch + Lomb is dedicated to protecting and enhancing the gift
of sight for millions of people around the world – from the moment
of birth through every phase of life. Its comprehensive portfolio
of more than 400 products includes contact lenses, lens care
products, eye care products, ophthalmic pharmaceuticals,
over-the-counter products and ophthalmic surgical devices and
instruments. Founded in 1853, Bausch + Lomb has a significant
global research and development, manufacturing and commercial
footprint with approximately 13,000 employees and a presence in
nearly 100 countries. Bausch + Lomb is headquartered in Vaughan,
Ontario with corporate offices in Bridgewater, New Jersey. For more
information, visit www.bausch.com and connect with us on X,
LinkedIn, Facebook and Instagram.
© 2024 Bausch + Lomb.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240103199281/en/
Media: T.J. Crawford tj.crawford@bausch.com (908)
705-2851
Investor: George Gadkowski george.gadkowski@bausch.com
(877) 354-3705 (toll free)
Bausch plus Lomb (NYSE:BLCO)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Bausch plus Lomb (NYSE:BLCO)
Historical Stock Chart
Von Mai 2023 bis Mai 2024